GlobalDeal

Clade Therapeutics

Biotechnology · Boston, United States

cladetx.com

About Clade Therapeutics

Clade Therapeutics is a biotechnology company focused on developing innovative therapies for genetic diseases. The company leverages advanced gene editing technologies to create targeted treatments that address the underlying causes of these conditions. Clade's research is centered on harnessing the power of CRISPR and other genomic tools to develop safe and effective therapies. The company aims to transform the landscape of genetic medicine by providing solutions that not only treat symptoms but also correct genetic defects at their source. Clade Therapeutics is committed to advancing its pipeline of therapies through rigorous clinical trials and collaborations with leading research institutions. With a strong emphasis on scientific excellence and patient-centric approaches, Clade is poised to make significant contributions to the field of biotechnology and improve the lives of patients with genetic disorders.

Company facts

Industry
Biotechnology
Sub-industries
Gene Therapy, Genetic Engineering, Pharmaceuticals, Research and Development, Clinical Trials
Location
Boston, United States
Employees
51–200
Founded
2018

Products and services

Open Clade Therapeutics in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →